Katsiki N - Search Results

1

Are we getting to lipid targets in real life?

Katsiki N, Mikhailidis DP, Athyros VG, Hatzitolios AI, Karagiannis A, Banach M. Katsiki N, et al. Arch Med Sci. 2010 Oct;6(5):639-41. doi: 10.5114/aoms.2010.17073. Epub 2010 Oct 26. Arch Med Sci. 2010. PMID: 22419917 Free PMC article. No abstract available.

2

Sodium-lithium countertransport activity in healthy, dyslipidemic, and hypertensive individuals.

Savopoulos CG, Hatzitolios AI, Katsiki NA, Baltatzi M, Kosmidou M, Raikos N, Mikhailidis DP, Ziakas AG, Kaiafa G, Tsesmeli N. Savopoulos CG, et al. Among authors: katsiki na. Angiology. 2008 Dec-2009 Jan;59(6):727-35. doi: 10.1177/0003319708319784. Epub 2008 Oct 7. Angiology. 2008. PMID: 18840623

3

Is the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review.

Hatzitolios A, Iliadis F, Katsiki N, Baltatzi M. Hatzitolios A, et al. Among authors: katsiki n. Clin Exp Hypertens. 2008 Oct;30(7):628-39. doi: 10.1080/10641960802443274. Clin Exp Hypertens. 2008. PMID: 18855266 Free article. Review.

4

Implementation of strategy for the management of overt dyslipidemia: the IMPROVE-dyslipidemia study.

Hatzitolios AI, Athyros VG, Karagiannis A, Savopoulos C, Charalambous C, Kyriakidis G, Milidis T, Papathanakis C, Bitli A, Vogiatsis I, Ntaios G, Katsiki N, Symeonidis A, Tziomalos K, Mikhailidis DP; IMPROVE Collaborative Group. Hatzitolios AI, et al. Among authors: katsiki n. Int J Cardiol. 2009 May 29;134(3):322-9. doi: 10.1016/j.ijcard.2009.02.001. Epub 2009 Mar 6. Int J Cardiol. 2009. PMID: 19268376 Clinical Trial.

5

The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

Katsiki N, Georgiadou E, Hatzitolios AI. Katsiki N, et al. Drugs. 2009 Jul 30;69(11):1417-31. doi: 10.2165/00003495-200969110-00001. Drugs. 2009. PMID: 19634921 Review.

6

Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?

Katsiki N, Tziomalos K, Chatzizisis Y, Elisaf M, Hatzitolios AI. Katsiki N, et al. Atherosclerosis. 2010 Jul;211(1):9-14. doi: 10.1016/j.atherosclerosis.2009.12.028. Epub 2009 Dec 29. Atherosclerosis. 2010. PMID: 20060525 Review.

7

Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.

Tziomalos K, Dimitroula HV, Katsiki N, Savopoulos C, Hatzitolios AI. Tziomalos K, et al. Among authors: katsiki n. Mediators Inflamm. 2010;2010:364957. doi: 10.1155/2010/364957. Epub 2010 Mar 7. Mediators Inflamm. 2010. PMID: 20224654 Free PMC article. Review.

8

Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.

Katsiki N, Hatzitolios AI. Katsiki N, et al. Curr Opin Obstet Gynecol. 2010 Dec;22(6):466-76. doi: 10.1097/GCO.0b013e32833e1264. Curr Opin Obstet Gynecol. 2010. PMID: 20724929 Review.

9

Ezetimibe in diabetes: more than cholesterol lowering?

Sarigianni M, Katsiki N, Mikhailidis DP. Sarigianni M, et al. Among authors: katsiki n. Curr Med Res Opin. 2010 Oct;26(10):2517-20. doi: 10.1185/03007995.2010.518519. Curr Med Res Opin. 2010. PMID: 20843163

10

Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al.

Sarigianni M, Katsiki N, Mikhailidis DP. Sarigianni M, et al. Among authors: katsiki n. Diabetes Care. 2010 Oct;33(10):e132; author reply e133. doi: 10.2337/dc10-1250. Diabetes Care. 2010. PMID: 20876706 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters